I have messed around today with a few 2,000+ trades. The sells never changed the level II.

Interesting day.

?Positive! Appears they did not have a shelf filing for warrants. Do they expect them to be exercised soon?? If so, extremely positive!?

Did they not have an s1 for outstanding warrants?? Look to only cover those.

Offering link: https://t.co/4rIpnEV4J5

S-1 registering 6.8 million shares for offering.

The post is still spot on. Day trading was a huge part of the volume this week. Nothing wrong with it.

Monday will be interesting. I’m guessing at least 10% up or down.

Lots of resistance at $2.50 but great day so far!

Not flirting anymore!

MMs not having much luck this morning. Dropped it to $1.96 and a 10,000 share bid at $1.96 jumped it right back above $2.00.

Looking forward to see where we end today. Anything over $2 is a positive!

Any thoughts? Seems neutral and maybe a little negative for anyone wanting a deal done soon.

Just reviewed 8-k from today and appears accurate. Salary of $400,000 and Punit gets $428,000 with option to take salary in stock.

Dan’s stock is an option to purchase at $1.25.

From Twitter:

$oncs The new CEO is given 7% ownership in the company.(2 million shares + another 500k at year end). He is very incentivized.

With all studies being completed with Keytruda, would ONCS have to start over with trials for other indications?

I agree licensing could be lucrative but what’s the timeline for usage with other indications?

Thank you for the insightful post.

Thanks for sharing this very positive article. Are you projecting $ONCS to be $2.50 next week or in a couple of months?

I’m curious for more information but he’s a lawyer which bodes well for a buyout or other other late stage items.

??????

That’s a pretty consistent message. Where there’s smoke there’s fire.

Where did Titan V’s sticky go about Merck potentially being the unnamed investor for 3 fund raises since 2013???

Positive news this morning. Will ONCS need to raise funds for registration trial? Kept on eye on ONCS but waiting for right time to reenter.

Earnings are expected Wednesday, 8/23, according to TD Ameritrade.

Ash has definitely been off on this one like many others have. His track record overall speaks for itself. His DD has always been good regardless of stock choice.

GE at this point has $100 million invested in common stock. So I like the odds of this stock having large gains. GE not being able to sell common stock for 6 months is huge imo. I don’t expect it but 6 months from now GE may go back to his old ways. Time will tell but I’m fairly confident we will see big gains with DRYS prior to seeing any bigs dips.

There won’t be much movement until Wednesday. Fully expect slight gains until earnings are released Wednesday (assuming they don’t delay again). There will be a run up to $4 on Wednesday and then anyone’s guess from there.

My best guess is good earnings. Nothing spectacular but good enough to let the stock run to $5 by EOW.

Near the middle.

I loaded the boat this week but fully expect it to settle lower before any upward movement occurs.

Need a formal partnership or this is going no where fast. IMO

No, it's saying things will most likely stay the same. Keytruda provided for free by Merck.

That would be amazing! I'd love to see that buying opportunity!

Filled 500 of a 4,500 share bid at $0.87. Grr. Picking up steam!

Glad it's your money and not mine.

$DRYS getting some life in her.

I sold at $0.105 this morning. A little early but happy with it! Thanks Ash.

Moved over to $DRYS.... we'll see what happens...

$IDXG hitting 52-week lows.

ONCS - Solid interim results on melanoma patients!

26% complete response on expected non-responders to PD1 alone. Plus another 14% partial response. With only 30% responders to pd1 alone.

http://ir.oncosec.com/press-releases/detail/1885

Agree. That is where my confidence for data this week is coming from.

We'll know soon!

Been sitting out for several months but got back in with a full position Friday. Its been a crazy ride since my first buy in at $0.30 ($6 post RS)

ONCS - Anybody watching this for next week? Interim data for Phase II combo with Merck's Keytruda at SITC.

I'm expecting very but results but I've been wrong on this one several times before. Positive news would be big!

http://ir.oncosec.com/press-releases/detail/1884/oncosec-to-present-at-scientific-and-investment-conferences

SAEX- 96,000 buy order a $7.00.

Jumped in and out this morning for a decent 30 minute profit.

OPXAW- What is strike price and time frame?

Baker Brothers

Never looked at ITCI but looks like a decent bounce play. Jumped in at $15.06 with 200 shares.